Samsung Biologics Co.,Ltd. (207940.KS) KSC

Currency In KRW

Samsung Biologics Co.,Ltd.

Address

300, Songdo Bio-daero

Incheon, 21987

Korea (the Republic of)

Phone

82 3 2455 3114

Website

https://samsungbiologics.com

Sector

Healthcare

Industry

Biotechnology

Employees

4770

First IPO Date

November 11, 2016

Key Executives

Name	Title	Pay	Year Born
John Chongbo Rim	Chief Executive Officer, President & Chairman of Board	7.9B	1961
James J. Choi	Executive Vice President, Head of CDO Development Center & Head of Sales Center	569M	1967
Kun Lo	Executive Vice President, Head of EPCV Center & Director	2.2B	1963
Kyuho Lee	Executive Vice President, Head of People Center, & Chief Human Resource Officer	0	N/A
Pierre Catignol	Executive Vice President & Head of Operation Center	0	1968
Heekyun Lim	Vice President & Head of Business Consulting Team	0	1975
Kevin Sharp	EVP, Head of Sales & Operations Department	0	N/A
Seungho Ryu	EVP, CFO, Head of Business Support Center & Director	0	1968
Heejeong Kim	VP & Head of DS Department	0	N/A
Sojeong Lee	Vice President & Head of Regulatory Affairs	0	N/A

Description

Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.